Abiomed, Inc.

ABMD
Delayed Nasdaq - 12/13 10:00:00 pm
181.85USD
+1.51%
Prev.179.1500
Open179.1500
High183.1300
Low175.2500
Volume490 557
Financials
Sales 2020 886 M
EBIT 2020 262 M
Net income 2020 208 M
Finance 2020 786 M
Yield 2020 -
P/E ratio 2020 40,0x
P/E ratio 2021 34,5x
EV / Sales2020 8,38x
EV / Sales2021 6,92x
Capitalization 8 211 M
Company
Abiomed, Inc. specializes in the development, manufacturing and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows:
- product sales (96.4%): heart pumps (Impella brand);
- service provision (3.6%): including...
Sector :
Advanced Medical Equipment & Technology - NEC
Calendar :
2020-01-30 Earnings Release
Trading Rating :
Investor Rating :
Latest news
11/27ABIOMED : to Present at the 31st Annual Piper Jaffray Healthcare Conference
BU
11/19ABIOMED : Medical Office Completes Review of Observational Analysis of Impella Presented at AHA
BU
11/14ABIOMED : Clinical Review Demonstrates Cost-Effectiveness of Impella in High-Risk PCI and Cardiogenic Shock
BU
10/31ABIOMED INC : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
10/31ABIOMED INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
10/31ABIOMED : Fiscal 2Q Earnings Snapshot
AQ
10/31ABIOMED : First U.S. Patients Treated with Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump
BU
10/31ABIOMED : Announces Q2 FY 2020 Revenue of $205 Million and 29.4% Operating Margin
BU
Technical analysis trends
Short TermMid-TermLong Term
TrendBearishNeutralBearish
Resistance201279251
Spread/Res.-9,4%-35%-28%
Spread/Supp.2,1%14%7,4%
Support178159169